Comparing the efficacy of hypnosis and the muscle relaxation in the symptom-relief of premenstrual syndrome

authors:

avatar Zahra Asgariani , avatar Shahnaz Barat , avatar Sussan Moudi ORCID , * , avatar Angela Hamidia , avatar A. li Bijani


how to cite: Asgariani Z, Barat S, Moudi S, Hamidia A, Bijani A L. Comparing the efficacy of hypnosis and the muscle relaxation in the symptom-relief of premenstrual syndrome. koomesh. 2018;20(3):e152987. 

Abstract

Introduction: Premenstrual syndrome (PMS) is a common health problem in women in reproductive age which can impact their performance and quality of life. Considering drug- related side effects and limited evidences supporting the efficacy of hypnosis in PMS, the present study aimed to compare the effectiveness of hypnosis and the muscle relaxation in the symptom-relief of premenstrual syndrome. Materials and Methods: This randomized controlled clinical trial (RCT) was conducted on all 38 women with diagnostic criteria of premenstrual dysphoric disorder (based on DSM IV) who were referred to the clinics of Yahyanejad and Rohani Hospital in Babol (Iran) in 2016. They were allocated into two groups randomly. The first group received muscle relaxation and the second group received hypnotherapy. The patients filled out PMS symptom severity questionnaires at baseline, the 1st and 3rd months after intervention. Eight patients lost the follow up therefore, data related to 30 patients was analyzed Results: Data analysis showed that the two groups were similar in demographic characteristics (P > 0.05). Mean of symptom severity score decreased significantly in the hypnotherapy group in comparison with the muscle relaxation group (p < 0.05) Conclusion: It seems that hypnosis can be significantly effective in the treatment of PMS and can reduce its symptoms.

References

  • 1.

    Imai A, Ichigo S, Matsunami K, Takagi H. Premenstrual syndrome: management and pathophysiology. Clin Exp Obstet Gynecol 2015; 42: 123-128.

  • 2.

    Ryu A, Kim TH. Premenstrual syndrome: A mini review. Maturitas 2015; 82: 436-440.

  • 3.

    Sammon CJ, Nazareth I, Petersen I. Recording and treatment of premenstrual syndrome in UK general practice: a retrospective cohort study. BMJ Open 2016; 6: e010244.

  • 4.

    Fathizadeh N, Ebrahimi E, Valiani M, Tavakoli N, Yar MH. Evaluating the effect of magnesium and magnesium plus vitamin B6 supplement on the severity of premenstrual syndrome. Iran J Nurs Midwifery Res 2010; 15: 401-405.

  • 5.

    Chocano-Bedoya PO, Manson JE, Bertone-Johnson ER. Dietary B vitamin intake and incident premenstrual syndrome. Am J Clin Nutr 2011; 93: 1080-1086.

  • 6.

    Freeman EW, Halberstadt SM, Rickels K, Legler JM, Lin H, Sammel MD. Core symptoms that discriminate premenstrual syndrome. J Womens Health 2011; 20: 29-35.

  • 7.

    Direkvand-Moghadam A, Sayehmiri K, Delpisheh A, Kaikhavandi S. Epidemiology of premenstrual syndrome (PMS)-A systematic review and meta-analysis Study. J Clin Diagn Res 2014; 8: 106-109.

  • 8.

    Ebrahimi E, Khayati Motlagh Sh, Nemati S, Tavakoli Z. Effects of magnesium and vitamin B6 on the severity of premenstrual syndrome symptoms. J Caring Sci 2012; 1: 183-189.

  • 9.

    Bakhshani NM, Mousavi MN, Khodabandeh G. Prevalence and severity of premenstrual symptoms among Iranian female university students. J Pak Med Assoc 2009; 59: 205-208.

  • 10.

    Delaram M, Kheiri S, Hodjati MR. Comparing the effects of echinophora-platyloba, fennel and placebo on pre-menstrual syndrome. J Reprod Infertil 2011; 12: 221-226.

  • 11.

    Freeman EW. Therapeutic management of premenstrual syndrome. Expert Opin Pharmacother 2010; 11: 2879-2889.

  • 12.

    Biggs WS, Demuth RH. Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Am Fam Physician 2011; 84: 918-924.

  • 13.

    The American College of Obstetricians and Gynecologists. Premenstrual Syndrome (PMS). Frequently asked questions. 2015; FAQ057 Gynecologic Problems. Available from: https://www.acog.org/Patients/FAQs/Premenstrual-Syndrome-PMS.

  • 14.

    [ 14] Karimi Z, Dehkordi MA, Alipour A, Mohtashami T. Treatment of premenstrual syndrome: Appraising the effectiveness of cognitive behavioral therapy in addition to calcium supplement plus vitamin D. Psych J 2018; 7: 41-50.

  • 15.

    Jasuja V, Purohit G, Mendpara S, Palan BM. Evaluation of psychological symptoms in premenstrual syndrome using PMR technique. J Clin Diagn Res 2014; 8: BC01-BC3.

  • 16.

    Rapkin AJ, Lewis EI. Treatment of premenstrual dysphoric disorder. Womens Health (Lond). 2013; 9: 537-556.

  • 17.

    Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci 2008; 33: 291-301.

  • 18.

    Sharifirad G, Rabiei L, Hamidizadeh S, Bahrami N, Rashidi Nooshabadi MR, Masoudi R. The effect of progressive muscle relaxation program on the depression anxiety, and stress of premenstrual syndrome in female students. J Health Syst Res 2014; 1786-1796.

  • 19.

    Jazayeri S, Ahadi H, Jomehri F, Mehryar AH. Comparison of the effectiveness of relaxation therapy and pharmaceutical therapy in decreasing the symptoms of premenstrual syndrome. J Thought Behav Clin Psychol 2013; 8: 37-46.

  • 20.

    Samadi Z, Taghian F, Valiani M. The effects of 8 weeks of regular aerobic exercise on the symptoms of premenstrual syndrome in non-athlete girls. Iran J Nurs Midwifery Res 2013; 18: 14-19.

  • 21.

    Sadock BJ, Kaplan HI, Sadock VA. Kaplan and Sadocks Synopsis of psychiatry: Behavioral Sciences and Clinical Psychiatry. 10th ed., editor. Philadelphia: Lippincott Wiliams & Wilkins; 2007.

  • 22.

    Moghtader L, Hasanzade R, Mirzaeian B, Dusti Y. Effectiveness of group cognitive behavioral therapy and group cognitive hypnotism on anxiety and depression in women with premenstrual syndrome. Holist Nurs Midwifery 2016; 26: 96-105.

  • 23.

    Hajian-Tilaki K. Sample size estimation in epidemiologic studies. Caspian J Intern Med 2011; 2: 289-298.

  • 24.

    Lee JS, Pyun YD. Use of hypnosis in the treatment of pain. Korean J Pain 2012; 25: 75-80.

  • 25.

    Jensen MP, Patterson DR. Hypnotic approaches for chronic pain management. clinical implications of recent research findings. Am Psychol 2014; 69: 167-177.

  • 26.

    Hariri FZ, Moghaddam-Banaem L, Siah Bazi S, Saki Malehi A, Montazeri A. The Iranian version of the premenstrual symptoms screening tool (PSST): a validation study. Arch Womens Ment Health 2013; 16: 531-537.

  • 27.

    Bosman RC, Jung SE, Miloserdov K, Schoevers RA, aan het Rot M. Daily symptom ratings for studying premenstrual dysphoric disorder: A review. J Affect Disord 2016: 43-53.

  • 28.

    Hammond DC. Hypnosis in the treatment of anxiety- and stress-related disorders. Expert Rev Neurother 2010; 10: 263-273.

  • 29.

    Shah M, Monga A, Patel S, Shah M, Bakshi H. The effect of hypnosis on dysmenorrhea. Int J Clin Exp Hypn 2014; 62: 164-178.

  • 30.

    Shah M, Monga A, Patel SV, Shah M, Bakshi H. Pain relief in dysmenorrhea: Exploring hypnosis as an alternative therapy. CHRISMED J Health Res 2016; 3:197-202.

  • 31.

    Sharifirad G, Rabiei L, Hamidizadeh S, Bahrami N, Rashidi Nooshabadi MR, Masoudi R. Comparing the effectiveness of cognitive behavioral therapy and hypnosis therapy pain self-efficacy and pain severity in girls with primary dysmenorrhea. Armaghane-danesh 2017; 22: 87-103. (Persian).

  • 32.

    Cramer H, Lauche R, Paul A, Langhorst J, Kummel S, Dobos G. Hypnosis in breast cancer care: a systematic review of randomized controlled trials. Integr Cancer Ther 2015; 14: 5-15.

  • 33.

    Vyas R, Adwanikar G, Hathi L, Vyas B. Psychotherapeutic intervention with hypnosis in 554 couples with reproductive failure. J Indian Med Assoc 2013; 111: 167-173.

  • 34.

    Zalipour S, Momeni Kh. The effectiveness of relaxation on premenstrual syndrome. Res Med 2014; 38: 157-161.

  • 35.

    Hariharan C, Sinha A, Chaudhary RK. A review of the current status of mind body medicine in obstetric and gynecology practice. J South Asian Feder Obst Gynae 2013; 5: 7-21.##.